id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-0746-0001,FDA,FDA-2026-N-0746,"Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for
Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing
Technologies Designation Program",Notice,60 Day Proposed Information Collection,2026-02-20T05:00:00Z,2026,2,2026-02-20T05:00:00Z,2026-04-22T03:59:59Z,2026-02-21T10:00:24Z,2026-03326,1,0,09000064b91c75af